Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

AIDS 2012: New Frontiers in NIH AIDS Research

AIDS 2012: New Frontiers in NIH AIDS Research

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

What are the biggest research challenges ahead in the effort to turn the tide against AIDS? How close are we to developing effective microbicides or vaccines? And is a cure for HIV infection really possible? This interative satellite with leading researchers from the U.S. National Institutes of Health (NIH) will outline the most important advances and challenges in AIDS research to date, including efforts to develop:

  • Better methods to prevent, identify and treat HIV and its co-infections, malignancies and complications
  • Improved biomedical and behavioral prevention tools, including Treatment as Prevention, microbicides, pre-exposure prophylaxis (PrEP) and vaccines
  • Strategies to understand the factors that affect HIV risk, treatment outcomes, and disease progression among different populations
  • New treatment and prevention strategies for substance users
  • Approaches to overcome drug resistance and treatment failure and to eradicate persistent HIV viral reservoirs, that may one day lead to a cure.

Welcome

  • Dr. Jack Whitescarver, Director, NIH Office of AIDS Research, USA, United States

The NIH: Turning Discovery into Health

  • Dr. Francis Collins, Director, National Institutes of Health, USA, United States

NIAID HIV/AIDS Research: Introduction and Overview

  • Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID), NIH, USA, United States

NIH AIDS Research Achievements and Challenges

  • Dr. Carl Dieffenbach, Director, Division of AIDS, NIAID, NIH, USA, United States

Understanding Neuro-AIDS and Implications for the Cure

  • Dr. Avindra Nath, Intramural Clinic Director, National Institute of Neurological Disorders and Stroke, NIH, USA, United States

Advances in Treating and Preventing HIV in Substances Users

  • Dr. Nora D. Volkow, Director, National Institute on Drug Abuse, NIH, USA, United States

New Challenges in HIV-defining and Non-defining Malignancies

  • Dr. Robert Yarchoan, Director, Office of HIV and AIDS Malignancy, National Cancer Institute, NIH, USA, United States

Panel Discussion: Implications of Scientific Advances for Populations at Risk: Perspectives from Researchers, Clinicians, and the Community

  • Dr. Gina Brown, NIH Office of AIDS Research, NIH, United States
  • Dr. Victoria Cargill, NIH Office of AIDS Research, NIH, United States
  • Dr. Basil Eldadah, National Institute on Aging, NIH, United States
  • Dr. Bill D. Kapogiannis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, United States

Questions and Answers
 

Event Date

Jul 22, 2012